Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover
Lineage Cell Therapeutics, Inc. (LCTX) had Days Sales in Receivables of 22.34 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$14.56M |
|
$-63.53M |
|
$0.15M |
|
$14.41M |
|
$51.17M |
|
$-36.62M |
|
$-32.03M |
|
$-68.65M |
|
$-68.64M |
|
$-63.37M |
|
$-63.37M |
|
$-63.37M |
|
$-63.36M |
|
$-36.62M |
|
$-21.14M |
|
230.12M |
|
230.12M |
|
$-0.28 |
|
$-0.28 |
|
| Balance Sheet Financials | |
$59.16M |
|
$2.57M |
|
$53.43M |
|
$112.58M |
|
$11.37M |
|
$0.03M |
|
$57.87M |
|
$69.24M |
|
$43.35M |
|
$0.97M |
|
$43.35M |
|
243.12M |
|
| Cash Flow Statement Financials | |
$-18.92M |
|
$-13.46M |
|
$26.95M |
|
$46.35M |
|
$41.32M |
|
$-5.03M |
|
$4.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.20 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
99.00% |
|
-251.57% |
|
-251.57% |
|
-145.22% |
|
-471.61% |
|
-436.47% |
|
$-19.44M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
-- |
|
16.34 |
|
|
Days Sales in Receivables |
22.34 |
-146.19% |
|
-6505.86% |
|
-56.28% |
|
-146.08% |
|
$0.18 |
|
$-0.08 |
|
$-0.08 |
|